相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Hepatitis C Vi(KLH偶联合成肽)
- 亚型:
IgG
- 形态:
液体
- 保存条件:
4℃运输,-20℃保存,避免反复冻融
- 克隆性:
多克隆
- 标记物:
不标记
- 适应物种:
HCV
- 宿主:
兔
- 应用范围:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200 (石蜡切片需做抗原修复)<br />not yet tested in other applications.<br>optimal dilutions/concentrations should be determined by the end user.
- 浓度:
1mg/1ml
- 靶点:
Hepatitis C Virus NS5a
- 抗体英文名:
Rabbit Anti-Hepatitis C Virus NS5a antibody
- 抗体名:
丙型肝炎病毒NS5A/Hepatitis C Virus NS5抗体
- 规格:
0.1ml/0.2ml
| 规格: | 0.1ml | 产品价格: | ¥800.0 |
|---|---|---|---|
| 规格: | 0.2ml | 产品价格: | ¥1280.0 |
中文名称:丙型肝炎病毒NS5A/Hepatitis C Virus NS5抗体
英文名称:Rabbit Anti-Hepatitis C Virus NS5a antibody
产品规格:0.1ml|0.2ml
宿主物种:兔
交叉反应:HCV
克隆类型:多克隆
分 子 量:49kDa
浓 度:1mg/1ml
亚 型:IgG
细胞定位:细胞浆 细胞膜
免 疫 原:KLH conjugated synthetic peptide derived from Hepatitis C Vi
纯化方法:蛋白A亲和纯化
产品应用:WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
石蜡切片需做抗原修复;
尚未测试其他应用;
实际稀释和工作浓度用户可根据具体用途酌情决定。
储 存 液:0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol
保存条件:4℃运输,-20℃保存,避免反复冻融
研究领域:免疫学 细菌及病毒
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification and Crystallization of NS5A Domain I of Hepatitis C Virus
The NS5A protein of HCV is an essential component of the viral RNA replication machinery and may also function in modulation of the host cell environment. The exact function of NS5A in these processes remains unknown. NS5A is a large
Genotyping Hepatitis C Virus by Type-Specific Primers for PCR Based on NS5 Region
Hepatitis C virus (HCV), a flavi-like virus with a positive-sense, single-stranded genome RNA (1 –3 ), shows considerable variation in nucleotide sequences. These variations fall into a series of specific patterns and are the basis
Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B Polymerase)
The hepatitis C virus (HCV) chronically infects approx 4 million patients in the United States alone, and constitutes a major cause of chronic liver disease and hepatocellular carcinoma (1 –3 ). Current antiviral therapies for chronic
技术资料暂无技术资料 索取技术资料








